新股消息 | 蔓迪国际递表港交所

Core Insights - Mandee International has submitted its application to list on the Hong Kong Stock Exchange, with Huatai International as its sole sponsor [1] - The company is recognized as a leading professional consumer pharmaceutical company in China, focusing on skin health and weight management solutions [1] - Mandee International has established a leading position in the hair health sector within the broader skin health industry [1] Market Position - According to Zhi Shi Consulting, Mandee's flagship product, the Mandee® series minoxidil hair loss treatment, has ranked first in the Chinese hair loss medication market and the minoxidil drug market for ten consecutive years since 2014 [1] - The market shares for these two segments in 2024 are projected to be approximately 57% and 71%, respectively [1] Product Launch - In March 2025, Mandee International will launch the Mandee® anti-hair loss shampoo, which is the first shampoo in China to include the anti-hair loss ingredient Unodial [1] - The product achieved over 500,000 bottles in sales within the first six months of its launch, redefining the domestic anti-hair loss and hair care market landscape [1]